Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Results 1 - 10 of 28 for RUXOLITINIB
  1. Ruxolitinib 
    Ruxolitinib is used to treat myelofibrosis (a cancer of the bone marrow in which the bone marrow ... not able to be treated successfully with hydroxyurea. Ruxolitinib is also used to treat acute graft versus ...
    https://medlineplus.gov/druginfo/meds/a612006.html - Drugs and Supplements
  2. Ruxolitinib Topical 
    Topical ruxolitinib is used to treat the symptoms of eczema (atopic dermatitis; a skin disease that causes the skin ... whose eczema has not responded to another medication. Ruxolitinib is in a class of medications called Janus ...
    https://medlineplus.gov/druginfo/meds/a621053.html - Drugs and Supplements
  3. Primary Myelofibrosis From the National Institutes of Health (National Cancer Institute)  
    Myeloproliferative neoplasms treatments vary and depend upon the specific diagnosis. Treatment may include observation, phlebotomy, transfusions, chemotherapy/ ...
    https://www.cancer.gov/.../patient/chronic-treatment-pdq#_234 - External Health Links
  4. Chronic Myeloproliferative Neoplasms Treatment From the National Institutes of Health (National Cancer Institute)  
    Myeloproliferative neoplasms treatments vary and depend upon the specific diagnosis. Treatment may include observation, phlebotomy, transfusions, chemotherapy/ ...
    https://www.cancer.gov/.../patient/chronic-treatment-pdq - External Health Links
  5. Essential Thrombocythemia From the National Institutes of Health (National Cancer Institute)  
    Myeloproliferative neoplasms treatments vary and depend upon the specific diagnosis. Treatment may include observation, phlebotomy, transfusions, chemotherapy/ ...
    https://www.cancer.gov/.../patient/chronic-treatment-pdq#_245 - External Health Links
  6. Treatment Option Overview (Chronic Myeloproliferative Neoplasms) From the National Institutes of Health (National Cancer Institute)  
    Myeloproliferative neoplasms treatments vary and depend upon the specific diagnosis. Treatment may include observation, phlebotomy, transfusions, chemotherapy/ ...
    https://www.cancer.gov/.../patient/chronic-treatment-pdq#_28 - External Health Links
  7. General Information about Chronic Myeloproliferative Neoplasms From the National Institutes of Health (National Cancer Institute)  
    Bone Marrow Diseases/Specifics ... Bone Marrow Diseases ... Myeloproliferative neoplasms treatments vary and depend upon the specific diagnosis. Treatment may include ...
    https://www.cancer.gov/.../patient/chronic-treatment-pdq#_1 - External Health Links
  8. Drugs Approved for Myeloproliferative Neoplasms or Myelodysplastic Syndromes From the National Institutes of Health (National Cancer Institute)  
    Bone Marrow Diseases/Treatments and Therapies ... Bone Marrow Diseases ... National Cancer Institute ... From the National Institutes of Health ... This page lists cancer ...
    https://www.cancer.gov/.../drugs/myeloproliferative-neoplasms - External Health Links
  9. Primary Immune Deficiency Diseases (PIDDs) From the National Institutes of Health (National Institute of Allergy and Infectious Diseases)  
    Immune System and Disorders/Start Here ... Immune System and Disorders ... National Institute of Allergy and Infectious Diseases ... From the National Institutes of ...
    https://www.niaid.nih.gov/...rimary-immune-deficiency-diseases-pidds - External Health Links
  10. Polycythemia vera 
    ... lower blood counts. Anagrelide to lower platelet counts. Ruxolitinib (Jakafi) to reduce the number of red blood ...
    https://medlineplus.gov/ency/article/000589.htm - Medical Encyclopedia
previous · 1 · 2 · 3 · next